Trillium Therapeutics Inc.

Report date
9/30/2021
Quarter
2021 Q3
Filed
11/15/2021
Shares
5,700,000
Value ($000)
100,092
Weight
1.6%
2020 Q1 - 2021 Q3 (7 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).